Annual Operating Expenses
$85.94 M
-$8.45 M-8.95%
December 31, 2022
Summary
- As of February 10, 2025, RVLP annual total operating expenses is $85.94 million, with the most recent change of -$8.45 million (-8.95%) on December 31, 2022.
- During the last 3 years, RVLP annual operating expenses has fallen by -$39.40 million (-31.44%).
Performance
RVLP Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Expenses
$14.43 M
-$2.39 M-14.21%
June 30, 2023
Summary
- As of February 10, 2025, RVLP quarterly total operating expenses is $14.43 million, with the most recent change of -$2.39 million (-14.21%) on June 30, 2023.
- Over the past year, RVLP quarterly operating expenses has dropped by -$6.91 million (-32.38%).
Performance
RVLP Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
RVLP Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -8.9% | -32.4% |
3 y3 years | -31.4% | -16.5% |
5 y5 years | -13.8% | -43.5% |
RVLP Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -8.9% | at low | -41.9% | at low |
5 y | 5-year | -31.4% | at low | -51.9% | at low |
alltime | all time | -31.4% | at low | -64.1% | at low |
RVL Pharmaceuticals Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Jun 2023 | - | $14.43 M(-14.2%) |
Mar 2023 | - | $16.82 M(-9.0%) |
Dec 2022 | $85.94 M(-8.9%) | $18.48 M(-13.7%) |
Sep 2022 | - | $21.42 M(+0.3%) |
Jun 2022 | - | $21.34 M(-13.6%) |
Mar 2022 | - | $24.70 M(-0.6%) |
Dec 2021 | $94.39 M(+9.5%) | $24.84 M(-5.3%) |
Sep 2021 | - | $26.22 M(+13.5%) |
Jun 2021 | - | $23.10 M(+20.6%) |
Mar 2021 | - | $19.16 M(-16.4%) |
Dec 2020 | $86.21 M | $22.92 M(-1.0%) |
Sep 2020 | - | $23.14 M(+33.8%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2020 | - | $17.29 M(-35.6%) |
Mar 2020 | - | $26.86 M(-10.5%) |
Dec 2019 | $125.35 M(+6.3%) | $30.02 M(-9.1%) |
Sep 2019 | - | $33.04 M(+7.0%) |
Jun 2019 | - | $30.87 M(-1.7%) |
Mar 2019 | - | $31.42 M(-16.3%) |
Dec 2018 | $117.94 M(+18.4%) | $37.54 M(+27.6%) |
Sep 2018 | - | $29.42 M(+15.2%) |
Jun 2018 | - | $25.54 M(-6.6%) |
Mar 2018 | - | $27.34 M(-31.9%) |
Dec 2017 | $99.64 M(+4.9%) | $40.16 M(+103.3%) |
Sep 2017 | - | $19.75 M |
Dec 2016 | $95.02 M | - |
FAQ
- What is RVL Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals annual operating expenses year-on-year change?
- What is RVL Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals quarterly operating expenses year-on-year change?
What is RVL Pharmaceuticals annual total operating expenses?
The current annual operating expenses of RVLP is $85.94 M
What is the all time high annual operating expenses for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high annual total operating expenses is $125.35 M
What is RVL Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, RVLP annual total operating expenses has changed by -$8.45 M (-8.95%)
What is RVL Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of RVLP is $14.43 M
What is the all time high quarterly operating expenses for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high quarterly total operating expenses is $40.16 M
What is RVL Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, RVLP quarterly total operating expenses has changed by -$6.91 M (-32.38%)